ALRISE offers its ImSus® encapsulation technology and service in order to optimize the product life cycle management of its partners as well as to enhance performance of its partners' drugs in development. This collaborative development strategy is achieved either with the originators of the drug or with generic producers.

Own Development

ALRISE Biosystems GmbH creates its own product pipeline by developing higher-valued formulations of drugs that are coming off patent protection. These super generic formulations allow ALRISE rapid access to the market while comprising a comparatively low level of risk.

ALRISE Biosystems GmbH
Robert-Roessle-Straße 10
13125 Berlin, Germany
Phone +49 30.94 89 24 83
Fax +49 30.94 89 24 82